Original news and analysis on international IP policy
A hundred years ago, Dutch physicist Heike Kamerlingh Onnes and his student Gilles Holst discovered a property that was to launch decades of fervent research to understand the phenomenon: Superconductivity. Today, researchers are still trying to find ways to use this remarkable property, but are celebrating the centenary of its discovery.
Governments meeting last week to discuss a possible new treaty on industrial design harmonisation snagged slightly at the end over how to chart a course to a treaty negotiation, but otherwise reported a smooth week of talks. Officials also agreed to plan a meeting on internet service provider liability.
World Intellectual Property Organization members congregated this week to advance work on a potential treaty on industrial designs, and to look into trademark protection against infringement on the internet, including through social media. But they ended early after nominal progress in these promising new areas for the United Nations agency.
Intellectual property is an available space in which any country can compete, but certain policies are helpful, the head of the World Intellectual Property Organization said today. And he described a global geographic shift in innovation away from Europe and the United States.
Scientific advances in life sciences, in particular health, are being evaluated by experts this week in Lyon, France, with the stated hope of bringing new answers to global health challenges, such as funding, costs, and innovation.
The research-based pharmaceutical industry is working to bring a fresh face to the international public health policy arena in Geneva, most recently through a new initiative on technology transfer. Working through the industry’s Geneva-based trade association, the effort to be seen in a more positive light comes after years of doubts about the transparency of its involvement in these issues and could change the tenor of international negotiations.
A list of briefs were filed Friday in support of maintaining the high standard in the United States for questioning the validity of patent. The decision of the Supreme Court expected in the coming months could have a major impact on patent law.
A top European pharmaceutical industry association has named a new director general, coming from Sweden.
Companies doing business in the United States have, for the past 15 months, found themselves in the cross-hairs. Bayer, Nike, L’Oreal, Sony, Wal-Mart, Novo Nordisk and hundreds of other firms have been sued for making or selling products displaying incorrect or expired patent numbers. And the liability for such false patent marking can be astronomical, with a defendant potentially facing fines of billions or even trillions of dollars.
The bill to reform United States patent law recently passed by the Senate purports to bring US law closer to laws of other major patent-filing nations. But how close would it come?